Analysis of Venezuelan Equine Encephalitis Replicon Particles Packaged in Different Coats

被引:8
作者
Kamrud, Kurt I. [1 ]
Alterson, Kim D. [1 ]
Andrews, Chasity [1 ]
Copp, Laura O. [2 ]
Lewis, Whitney C. [1 ]
Hubby, Bolyn [2 ]
Patel, Deepa [1 ]
Rayner, Jonathan O. [3 ]
Talarico, Todd [1 ]
Smith, Jonathan F. [1 ]
机构
[1] AlphaVax Inc, Res Triangle Pk, NC USA
[2] Liquidia Technol Inc, Res Triangle Pk, NC USA
[3] Midwest Res Inst, Kansas City, MO USA
来源
PLOS ONE | 2008年 / 3卷 / 07期
关键词
D O I
10.1371/journal.pone.0002709
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The Venezuelan equine encephalitis (VEE) virus replicon system was used to produce virus-like replicon particles (VRP) packaged with a number of different VEE-derived glycoprotein ( GP) coats. The GP coat is believed to be responsible for the cellular tropism noted for VRP and it is possible that different VEE GP coats may have different affinities for cells. We examined VRP packaged in four different VEE GP coats for their ability to infect cells in vitro and to induce both humoral and cellular immune responses in vivo. Methodology/Principal Findings: The VRP preparations were characterized to determine both infectious units (IU) and genome equivalents (GE) prior to in vivo analysis. VRP packaged with different VEE GP coats demonstrated widely varying GE/IU ratios based on Vero cell infectivity. BALB/c mice were immunized with the different VRP based on equal GE titers and the humoral and cellular responses to the expressed HIV gag gene measured. The magnitude of the immune responses measured in mice revealed small but significant differences between different GP coats when immunization was based on GE titers. Conclusions/Significance: We suggest that care should be taken when alternative coat proteins are used to package vector-based systems as the titers determined by cell culture infection may not represent accurate particle numbers and in turn may not accurately represent actual in vivo dose.
引用
收藏
页数:8
相关论文
共 45 条
[1]   A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus [J].
Aronson, JF ;
Grieder, FB ;
Davis, NL ;
Charles, PC ;
Knott, T ;
Brown, K ;
Johnston, RE .
VIROLOGY, 2000, 270 (01) :111-123
[2]   Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses [J].
Balasuriya, UBR ;
Heidner, HW ;
Davis, NL ;
Wagner, HM ;
Hullinger, PJ ;
Hedges, JF ;
Williams, JC ;
Johnston, RE ;
Wilson, WD ;
Liu, IK ;
MacLachlan, NJ .
VACCINE, 2002, 20 (11-12) :1609-1617
[3]   Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant venezuelan equine encephalitis virus replicon particles [J].
Balasuriya, UBR ;
Heidner, HW ;
Hedges, JF ;
Williams, JC ;
Davis, NL ;
Johnston, RE ;
MacLachlan, NJ .
JOURNAL OF VIROLOGY, 2000, 74 (22) :10623-10630
[4]   ATTENUATION OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS BY IN VITRO CULTIVATION IN GUINEA-PIG HEART CELLS [J].
BERGE, TO ;
TIGERTT, WD ;
BANKS, IS .
AMERICAN JOURNAL OF HYGIENE, 1961, 73 (02) :209-&
[5]   Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice [J].
Bernard, KA ;
Klimstra, WB ;
Johnston, RE .
VIROLOGY, 2000, 276 (01) :93-103
[6]   ATTENUATED MUTANTS OF VENEZUELAN EQUINE ENCEPHALITIS-VIRUS CONTAINING LETHAL MUTATIONS IN THE PE2 CLEAVAGE SIGNAL COMBINED WITH A 2ND-SITE SUPPRESSOR MUTATION IN E1 [J].
DAVIS, NL ;
BROWN, KW ;
GREENWALD, GF ;
ZAJAC, AJ ;
ZACNY, VL ;
SMITH, JF ;
JOHNSTON, RE .
VIROLOGY, 1995, 212 (01) :102-110
[7]   Alphavirus replicon particles as candidate HIV vaccines [J].
Davis, NL ;
West, A ;
Reap, E ;
MacDonald, G ;
Collier, M ;
Dryga, S ;
Maughan, M ;
Connell, M ;
Walker, C ;
McGrath, K ;
Cecil, C ;
Ping, LH ;
Frelinger, J ;
Olmsted, R ;
Keith, P ;
Swanstrom, R ;
Williamson, C ;
Johnson, P ;
Montefiori, D ;
Johnston, RE .
IUBMB LIFE, 2002, 53 (4-5) :209-211
[8]   Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles [J].
Davis, NL ;
Caley, IJ ;
Brown, KW ;
Betts, MR ;
Irlbeck, DM ;
McGrath, KM ;
Connell, MJ ;
Montefiori, DC ;
Frelinger, JA ;
Swanstrom, R ;
Johnson, PR ;
Johnston, RE .
JOURNAL OF VIROLOGY, 2000, 74 (01) :371-378
[9]   INVITRO SYNTHESIS OF INFECTIOUS VENEZUELAN EQUINE ENCEPHALITIS-VIRUS RNA FROM A CDNA CLONE - ANALYSIS OF A VIABLE DELETION MUTANT [J].
DAVIS, NL ;
WILLIS, LV ;
SMITH, JF ;
JOHNSTON, RE .
VIROLOGY, 1989, 171 (01) :189-204
[10]   ATTENUATING MUTATIONS IN THE E2-GLYCOPROTEIN GENE OF VENEZUELAN EQUINE ENCEPHALITIS-VIRUS - CONSTRUCTION OF SINGLE AND MULTIPLE MUTANTS IN A FULL-LENGTH CDNA CLONE [J].
DAVIS, NL ;
POWELL, N ;
GREENWALD, GF ;
WILLIS, LV ;
JOHNSON, BJB ;
SMITH, JF ;
JOHNSTON, RE .
VIROLOGY, 1991, 183 (01) :20-31